Literature DB >> 15334542

Comparative expressed sequence hybridization studies of high-hyperdiploid childhood acute lymphoblastic leukemia.

Alicja M Gruszka-Westwood1, Sharon W Horsley, Angel Martinez-Ramirez, Christine J Harrison, Helena Kempski, Anthony V Moorman, Fiona M Ross, Michael Griffiths, Mel F Greaves, Lyndal Kearney.   

Abstract

The functional consequences of a high-hyperdiploid karyotype, found in up to one-third of cases of acute lymphoblastic leukemia (ALL), are unknown. Using the technique of comparative expressed sequence hybridization (CESH), we sought to address the question of whether increased chromosome copies in hyperdiploid ALL lead to increased gene expression. Relative expression of hyperdiploid ALL blasts versus peripheral blood mononuclear cells was analyzed in 18 patients. Common regions of overexpression corresponding to the presence of tri-/tetrasomies included: Xp22.1-22.2, 4q28, 6q14-15, 6q24, 10p13, 14q23-24, 17q21, 18q12, and 21q21, identified in 28-89% of cases. However, increased expression without underlying trisomy occurred at 3p21.3, 7q11.2, 8p21, and 8q24.1 in 39-90% of cases. High expression at 7q11.2, the most consistent change detected, was confirmed by quantitative PCR. Poor correlation between the presence of tri-/tetrasomy and overexpression was observed for chromosomes 14 and 17. Two cases were reanalyzed versus (i) B cells, (ii) transformed B cells, and (iii) CD34+19+ cells (the putative counterpart of the leukemic cell). A reduction in the number of relatively overexpressed regions was observed with CD34+19+ cells. In particular, the peak at 7q11.2 disappeared, suggesting up-regulation of genes from this region in the early ontology of normal B-cell development. In conclusion, we have shown that tri-/tetrasomies in hyperdiploid ALL lead to an increase in the expression of associated sequences. The choice of a biologically relevant reference is crucial for data interpretation. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334542     DOI: 10.1002/gcc.20085

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Genetic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Kajsa Paulsson; Erik Forestier; Henrik Lilljebjörn; Jesper Heldrup; Mikael Behrendtz; Bryan D Young; Bertil Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

Review 2.  The role of AUTS2 in neurodevelopment and human evolution.

Authors:  Nir Oksenberg; Nadav Ahituv
Journal:  Trends Genet       Date:  2013-09-02       Impact factor: 11.639

3.  High hyperdiploid childhood acute lymphoblastic leukemia: Chromosomal gains as the main driver event.

Authors:  Kajsa Paulsson
Journal:  Mol Cell Oncol       Date:  2015-07-06

Review 4.  Molecular cytogenetics in haematological malignancy: current technology and future prospects.

Authors:  Lyndal Kearney; Sharon W Horsley
Journal:  Chromosoma       Date:  2005-10-15       Impact factor: 4.316

5.  High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome.

Authors:  L Chilton; G Buck; C J Harrison; R P Ketterling; J M Rowe; M S Tallman; A H Goldstone; A K Fielding; A V Moorman
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

6.  CGH-Profiler: data mining based on genomic aberration profiles.

Authors:  Falk Schubert; Bernhard Tausch; Stefan Joos; Roland Eils
Journal:  BMC Bioinformatics       Date:  2005-07-25       Impact factor: 3.169

7.  Aberrant expression of homeobox gene SIX1 in Hodgkin lymphoma.

Authors:  Stefan Nagel; Corinna Meyer; Maren Kaufmann; Hans G Drexler; Roderick A F MacLeod
Journal:  Oncotarget       Date:  2015-11-24

8.  Specific expression of novel long non-coding RNAs in high-hyperdiploid childhood acute lymphoblastic leukemia.

Authors:  Mathieu Lajoie; Simon Drouin; Maxime Caron; Pascal St-Onge; Manon Ouimet; Romain Gioia; Marie-Hélène Lafond; Ramon Vidal; Chantal Richer; Karim Oualkacha; Arnaud Droit; Daniel Sinnett
Journal:  PLoS One       Date:  2017-03-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.